Manufacturing Facilities
VIRxSYS is the only company which has advanced lentiviral vectors into a Phase II clinical trial approved by the FDA. Consequently, VIRxSYS is uniquely positioned to manufacture clinical-grade lentiviral vectors for therapies treating a wide range of life-threatening diseases.
VIRxSYS can manufacture clinical grade lentiviral vectors for clinical trials at its Gaithersburg, Maryland facility. Our manufacturing facility includes two class-10,000 clean rooms for vector production. In addition, the company has a suite of quality control labs, and a variety of support rooms. The Company’s single-vector facility currently is being upgraded into a multi-product facility, which will allow for the production of multiple products and the ability to run multiple clinical programs simultaneously.
In addition to our manufacturing facilities, VIRxSYS has extensive research and development facilities and qualified staff, dedicated to supporting the Company’s manufacturing and clinical trial initiatives, and to developing a pipeline of therapies for additional disease indications.
"VIRxSYS's lentiviral manufacturing capabilities and cell processing are unmatched anywhere in the world."
Shuyuan Zhang, VIRxSYS VP Manufacturing